Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Demyelination in a patient receiving ustekinumab for refractory Crohn's disease.

× No keyword cloud information.

7 in total

Review 1. Ustekinumab in Crohn's disease: evidence to date and place in therapy.

Authors: Tal Engel; Uri Kopylov
Journal: Ther Adv Chronic Dis Date: 2016-07-06 Impact factor: 5.091

Review 2. A Practical Guide to the Safety and Monitoring of New IBD Therapies.

Authors: Benjamin Click; Miguel Regueiro
Journal: Inflamm Bowel Dis Date: 2019-04-11 Impact factor: 5.325

3. Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study.

Authors: Sailish Honap; Lulia Al-Hillawi; Samantha Baillie; Aaron Bancil; Lawrence Matini; Rebecca Lau; Klaartje Bel Kok; Kamal Patel; Alissa Walsh; Peter M Irving; Mark A Samaan
Journal: Frontline Gastroenterol Date: 2022-04-28

Review 4. Ustekinumab for the treatment of Crohn's disease: can it find its niche?

Authors: Ebby G Simon; Subrata Ghosh; Marietta Iacucci; Gordon W Moran
Journal: Therap Adv Gastroenterol Date: 2016-01 Impact factor: 4.409

Review 5. Next generation of biologics for the treatment of Crohn's disease: an evidence-based review on ustekinumab.

Authors: Aranzazu Jauregui-Amezaga; Michael Somers; Heiko De Schepper; Elisabeth Macken
Journal: Clin Exp Gastroenterol Date: 2017-11-15

Review 6. Advances in the development of new biologics in inflammatory bowel disease.

Authors: Bella Ungar; Uri Kopylov
Journal: Ann Gastroenterol Date: 2016-03-24

Review 7. Ustekinumab in treatment of Crohn's disease: design, development, and potential place in therapy.

Authors: Parakkal Deepak; Edward V Loftus
Journal: Drug Des Devel Ther Date: 2016-11-11 Impact factor: 4.162

7 in total